A.I. BURNASYAN FMBC CLINICAL BULLETIN

ISSN 2782-6430 (print)

State Research Center −Burnasyan Federal Medical Biophysical
Center of Federal Medical Biological Agency

The journal is published in Russian.
Format – A4.
The periodicity of the journal is 4 times a year.

Issue №2 2025 год

more

A.I. Burnasyan  FMBC clinical bulletin. 2025 № 1

I.N. Posokhov1,2, N.B. Yeshniyazov2, V.V. Medovchshikov2, B.K. Zholdin2, G.L. Kurmanalina2

Cumulative Blood Pressure: Calculation Method and Clinical Significance  
in Heart Failure with Preserved Ejection Fraction

1International Office, State Research Center – Burnasyan Federal Medical Biophysical Center  of Federal Medical Biological Agency, Moscow, Russiа

2West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan

Contact person: Posokhov Igor Nicolaevich: igor@posohov.ru

Abstract
Heart failure, a pressing issue in modern cardiology, occurs with preserved ejection fraction in more than 50% of cases. Screening and risk factor modification in HFpEF can be an effective strategy for improving long-term patient outcomes. One of the important components of such a strategy is hypertension control. Modern studies have shown that pharmaceutical control aimed not only at lowering baseline BP but also at minimizing its long-term impact leads to additional benefits for the patient, reducing cardiovascular morbidity and mortality, as well as the frequency of hospital readmissions. Our review reveals a method for calculating an indicator demonstrating the long-term impact of BP in heart failure and its clinical significance

Keywords: hypertension, cumulative blood pressure, heart failure with preserved ejection fraction

For citation: Posokhov IN, Yeshniyazov NB, Medovchshikov VV, Zholdin BK, Kurmanalina GL. Cumulative Blood Pressure: Calculation Method and Clinical Significance in Heart Failure with Preserved Ejection Fractions. A.I. Burnasyan Federal Medical Biophysical Center Clinical Bulletin. 2025.1:57-61. (In Russian) DOI: 10.33266/2782-6430-2025-1-57-61

 

REFERENCES

  1. Хроническая сердечная недостаточность: Клинические рекомендации / Российское кардиологическое общество // Российский кардиологический журнал. 2020. Т.25. №11. С. 4083 [Chronic Heart Failure: Clinical Guidelines. Russian Society of Cardiology. Rossiyskiy Kardiologicheskiy Zhurnal = Russian Cardiology Journal. 2020;25;11:4083 (In Russ.)]. doi.org/10.15829/1560-4071-2020-4083
  2. Шляхто Е.В., Беленков Ю.Н., Бойцов С.А. и др. Результаты промежуточного анализа проспективного наблюдательного многоцентрового регистрового исследования пациентов с хронической сердечной недостаточностью в Российской Федерации “ПРИОРИТЕТ-ХСН”: исходные характеристики и лечение первых включенных пациентов // Российский кардиологический журнал. 2023. Т.28. №10. С. 5593. [Shlyakhto Ye.V., Belenkov YU.N., Boytsov S.A., et al. Results of the Interim Analysis of the Prospective Observational Multicenter Registry Study of Patients with Chronic Heart Failure in the Russian Federation “PRIORITY-CHF”: Baseline Characteristics and Treatment of the First Included Patients. Rossiyskiy Kardiologicheskiy Zhurnal = Russian Cardiology Journal. 2023;28;10:5593 (In Russ.)]. doi.org/10.15829/1560-4071-2023-5593
  3. Жолдин Б.К., Ешниязов Н.Б., Медовщиков В.В., Курманалина Г.Л. Модифицируемые факторы риска и их влияние на развитие сердечно-сосудистых заболеваний // Медицинский журнал Западного Казахстана. 2017. Т.1. №53. С. 4-12 [Zholdin B.K., Yeshniyazov N.B., Medovshchikov V.V., Kurmanalina G.L. Modifiable Risk Factors and their Impact on the Development of Cardiovascular Diseases. Meditsinskiy Zhurnal Zapadnogo Kazakhstana = Medical Journal of Western Kazakhstan. 2017;1;53:4-12 (In Russ.)]. https://elibrary.ru/download/elibrary_32660758_27463815.pdf
  4. Hicklin H.E., Gilbert O.N., Ye F., Brooks J.E., Upadhya B. Hypertension as a Road to Treatment of Heart Failure with Preserved Ejection Fraction. Curr Hypertens Rep. 2020 Sep 3;22;10:82. doi.org/10.1007/s11906-020-01093-7
  5. Reges O., Ning H., Wilkins J.T., Wu C.O., Tian X., Domanski M.J., Lloyd-Jones D.M., Allen N.B. Association of Cumulative Systolic Blood Pressure with Long-Term Risk of Cardiovascular Disease and Healthy Longevity: Findings from the Lifetime Risk Pooling Project Cohorts. Hypertension. 2021 Feb;77;2:347-356. doi.org/10.1161/hypertensionaha.120.15650
  6. Huang R., Wu R., Lin Y., Zhong X., Ye X., Zhuang X., Liao X. Time-Averaged Cumulative Blood Pressure and Cardiovascular Outcomes in Heart Failure with Preserved Ejection Fraction: Analysis from the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial. J Hypertens. 2022 Oct 1;40;10:1918-1926. doi.org/10.1097/HJH.0000000000003177
  7. Padwal R., Campbell N.R.C., Schutte A.E., et al. Optimizing Observer Performance of Clinic Blood Pressure Measurement: a Position Statement from the Lancet Commission on Hypertension Group. J Hypertens. 2019 Sep;37;9:1737-1745. doi.org/10.1097/HJH.0000000000002112
  8. Посохов И.Н., Орлова О.С., Бородулина Т.А., Василишин Д.В. Расчет распространенных показателей вариабельности артериального давления при домашнем мониторировании с использованием электронных таблиц // Клинический вестник ФМБЦ им. А.И. Бурназяна. 2023. №4. С. 43-47 [Posokhov I.N., Orlova O.S., Borodulina T.A., Vasilishin D.V. Calculation of Common Indicators of Blood Pressure Variability During Home Monitoring Using Spreadsheets. Klinicheskiy Vestnik FMBTS im. A.I. Burnazyana = Clinical Bulletin of the A.I. Burnazyan Federal Medical and Biophysical Center. 2023;4:43-47 (In Russ.)]. doi.org/10.33266/2782-6430-2023-4-43-47
  9. Böhm M., Schumacher H., Teo K.K., et al. Achieved Blood Pressure and Cardiovascular Outcomes in High-Risk Patients: Results from ONTARGET and TRANSCEND Trials. Lancet. 2017 Jun 3;389;10085:2226-2237. doi.org/10.1016/S0140-6736(17)30754-7
  10. Lee J.H., Lee J.W., Youn Y.J., et al. Prognostic Impact of Preexisting Hypertension and High Systolic Blood Pressure at Admission in Patients Hospitalized for Systolic Heart Failure. J Cardiol. 2016 May;67;5:418-23. doi.org/10.1016/j.jjcc.2015.08.005
  11. Selvaraj S., Claggett B., Shah S.J., et al. Systolic Blood Pressure and Cardiovascular Outcomes in Heart Failure with Preserved Ejection Fraction: an Analysis of the Topcat Trial. Eur J Heart Fail. 2018 Mar;20;3:483-490. doi.org/10.1002/ejhf.1060
  12. Naderi SH, Bestwick JP, Wald DS. Adherence to Drugs that Prevent Cardiovascular Disease: Meta-Analysis on 376,162 Patients. Am J Med. 2012 Sep;125;9:882-7.e1 doi.org/10.1016/j.amjmed.2011.12.013
  13. Ference B.A., Bhatt D.L., Catapano A.L., et al. Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure with Lifetime Risk of Cardiovascular Disease. JAMA. 2019 Oct 8;322;14:1381-1391. doi.org/10.1001/jama.2019.14120
  14. Pool L.R., Ning H., Wilkins J., Lloyd-Jones D.M., Allen N.B. Use of Long-term Cumulative Blood Pressure in Cardiovascular Risk Prediction Models. JAMA Cardiol. 2018 Nov 1;3;11:1096-1100. doi.org/10.1001/jamacardio.2018.2763
  15. Wei F.F., Zhou Y., Wu Y., et al. Clinical Information from Repeated Blood Pressure Measurements in the Management of Heart Failure with Preserved Ejection Fraction. Hypertens. Res. 2023 Feb;46;2:475-484. doi.org/10.1038/s41440-022-01079-9
  16. Allen N.B., Siddique J., Wilkins J.T., Shay C., Lewis C.E., Goff D.C., Jacobs D.R. Jr, Liu K., Lloyd-Jones D. Blood Pressure Trajectories in Early Adulthood and Subclinical Atherosclerosis in Middle Age. JAMA. 2014 Feb 5;311;5:490-7. doi.org/10.1001/jama.2013.285122
  17. Kishi S., Teixido-Tura G., Ning H., et al. Cumulative Blood Pressure in Early Adulthood and Cardiac Dysfunction in Middle Age: The CARDIA Study. J Am Coll Cardiol. 2015 Jun 30;65;25:2679-87. doi.org/10.1016/j.jacc.2015.04.042
  18. Nwabuo C.C., Appiah D., Moreira H.T., et al. Long-Term Cumulative Blood Pressure in Young Adults and Incident Heart Failure, Coronary Heart Disease, Stroke and Cardiovascular Disease: the Cardia Study. Eur J Prev Cardiol. 2021 Oct 25;28;13:1445-1451. doi.org/10.1177/2047487320915342
  19. Jaroch J., Rzyczkowska B., Bociąga Z., et al. Arterial-Atrial Coupling in Untreated Hypertension. Blood Press. 2015 Apr;24;2:72-8. doi.org/10.3109/08037051.2014.986929
  20. Teramoto K., Nadruz Junior W., Matsushita K., et al. Mid- to Late-Life Time-Averaged Cumulative Blood Pressure and Late-Life Cardiac Structure, Function, and Heart Failure. Hypertension. 2020 Sep;76;3:808-818. doi.org/10.1161/hypertensionaha.120.14833
  21. Sandesara P.B., O’Neal W.T., Kelli H.M., Topel M., Samman-Tahhan A., Sperling L.S. Diastolic Blood Pressure and Adverse Outcomes in the TOPCAT (Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist) Trial. J Am Heart Assoc. 2018 Feb 23;7;5:e007475. doi.org/10.1161/JAHA.117.007475
  22. Посохов И.Н., Праскурничий Е.А. Что изменилось в домашнем мониторировании артериального давления за десятилетие // Российский кардиологический журнал. 2024. Т.29. №3S. С. 81-87 [Posokhov I.N., Praskurnichiy Ye.A. What has Changed in Home Blood Pressure Monitoring over the Past Decade? Rossiyskiy Kardiologicheskiy Zhurnal = Russian Journal of Cardiology. 2024;29;3S:81-87 (In Russ.)]. doi.org/10.15829/1560-4071-2024-5966

Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 11.09.2024. Accepted for publication: 15.10.2024

© 2025 Scientific journal - "Clinical Bulletin of the FMBС im. A.I. Burnasyan"
Scroll to Top